171 related articles for article (PubMed ID: 38675962)
1. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.
Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962
[TBL] [Abstract][Full Text] [Related]
2. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
[TBL] [Abstract][Full Text] [Related]
3. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
de Salazar A; Viñuela L; Fuentes A; Teyssou E; Charpentier C; Lambert-Niclot S; Serrano-Conde E; Pingarilho M; Fabeni L; De Monte A; Stefic K; Perno CF; Aguilera A; Falces I; Delgado R; Fernandes S; Diogo I; Gomes P; Paraskevis D; Santoro MM; Ceccherini-Silberstein F; Marcelin AG; Garcia F
Clin Infect Dis; 2023 May; 76(9):1628-1635. PubMed ID: 36571282
[TBL] [Abstract][Full Text] [Related]
4. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
Chen GJ; Cheng CY; Yang CJ; Lee NY; Tang HJ; Huang SH; Huang MH; Liou BH; Lee YC; Lin CY; Hung TC; Lin SP; Sun HY; Chang SY; Hung CC;
J Antimicrob Chemother; 2024 May; 79(5):1157-1163. PubMed ID: 38546761
[TBL] [Abstract][Full Text] [Related]
5. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
6. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
7. Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.
Pingarilho M; Pimentel V; Diogo I; Fernandes S; Miranda M; Pineda-Pena A; Libin P; Theys K; Martins MRO; Vandamme AM; Camacho R; Gomes P; Abecasis A
Viruses; 2020 Oct; 12(11):. PubMed ID: 33143301
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
9. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
Baxter JD; Dunn D; Tostevin A; Marvig RL; Bennedbaek M; Cozzi-Lepri A; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J;
HIV Med; 2021 May; 22(5):360-371. PubMed ID: 33369017
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
12. High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
Mboumba Bouassa RS; Mossoro-Kpinde CD; Gody JC; Veyer D; Péré H; Matta M; Robin L; Grésenguet G; Charpentier C; Bélec L
J Antimicrob Chemother; 2019 Jul; 74(7):2030-2038. PubMed ID: 30891603
[TBL] [Abstract][Full Text] [Related]
13. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
[TBL] [Abstract][Full Text] [Related]
14. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
[TBL] [Abstract][Full Text] [Related]
15. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
[TBL] [Abstract][Full Text] [Related]
17. Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance.
Novitsky V; Nyandiko W; Vreeman R; DeLong AK; Manne A; Scanlon M; Ngeresa A; Aluoch J; Sang F; Ashimosi C; Jepkemboi E; Orido M; Hogan JW; Kantor R;
Microbiol Spectr; 2022 Dec; 10(6):e0345422. PubMed ID: 36445146
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G
Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416
[TBL] [Abstract][Full Text] [Related]
19. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
[TBL] [Abstract][Full Text] [Related]
20. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
